Prendingue, Mansueto D.
HRN: 26-46-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2025
MUPIROCIN 2%, 15G (TUBE)
01/25/2025
02/01/2025
TOPICAL
Apply On Affected Are
BID
Decubitus Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes